Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

50.50
BATS BZX Real-Time Price
As of 11:05am ET
 +1.09 / +2.21%
Today’s Change
40.32
Today|||52-Week Range
58.59
+19.95%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line79.0M21.7M17.7M72.0M
 
 
 
 
 
Depreciation639.0K1.7M2.1M2.5M
 
 
 
 
 
Total Other Cash Flow13.9M8.6M12.5M14.7M
 
 
 
 
 
Funds From Operations93.5M29.6M30.7M91.0M
 
 
 
 
 
Funds From/For Other Operating Expenses16.8M-6.2M-22.0M61.8M
 
 
 
 
 
Net Cash Flow - Operating Activities76.7M35.8M52.7M29.2M
 
 
 
 
 
 
InvestingIncrease In Investments-196.3M-192.4M-251.4M-293.1M
 
 
 
 
 
Decrease In Investments110.6M153.5M249.3M260.7M
 
 
 
 
 
Capital Expenditures-2.3M-4.7M-2.5M-3.0M
 
 
 
 
 
Fixed Asset Disposal9.0K0.00----
 
 
Other Investing - Uses-172.0K0.000.000.00
 
 
Net Cash Flow Investing-88.2M-43.7M-4.6M-35.4M
 
 
 
 
 
 
FinancingShort Term Borrowings--0.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.00-68.0K-73.0K-79.0K
 
 
 
 
Net Proceeds Stock Sale726.0K1.7M1.1M6.2M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing1.8M1.0M213.0K0.00
 
 
 
 
Other Uses - Financing0.000.00202.0K1.8M
 
 
 
Net Cash Flow - Financing2.5M2.7M1.0M4.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-9.0M-5.1M49.1M-1.8M